Earnings call Advanced Enzyme Technologies posted strong Q2 FY26 results with 26% YoY revenue growth and 42% YoY EBITDA growth, achieving a 33% EBITDA margin. Despite a 1% QoQ revenue dip, PAT rose 11 ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Revenue: INR1,845 million, 26% year-on-year growth, 1% decrease quarter-on-quarter. EBITDA: INR601 million, 42% increase year-on-year, 6% increase quarter-on-quarter. EBITDA Margin: 33% for the ...

Rasika Rathi is a highly accomplished lawyer and board member of Specialty Enzymes & Probiotics, a group company of Advanced Enzyme Technologies. In her current role as general counsel of Advanced ...

(RTTNews) - Ecovyst Inc. (ECVT), a global leader in advanced materials and specialty catalysts, has signed a Memorandum of Understanding - MOU with Enzyme Supplies Ltd, a key player in industrial ...

MALVERN, Pa., Feb. 4, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts ...

Earnings call Advanced Enzyme Technologies reported FY25 revenue growth of 2% YoY and Q4 revenue up 6% YoY. EBITDA margins compressed to 27% in Q4 due to product mix and inventory adjustments.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.